Рак лёгких

SystImmune hits USD 250m milestone from BMS as iza-bren Phase III lung cancer trial advances

SystImmune hits USD 250m milestone from BMS as iza-bren Phase III lung cancer trial advances AllSci

About 30,000 new lung cancer cases occur yearly in Spain and Portugal; a trial has approval to screen patients there.

About 30,000 new lung cancer cases occur yearly in Spain and Portugal; a trial has approval to screen patients there. Stock Titan

This new drug could break cancer’s resistance to treatment

A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.

Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success?

Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success? The Motley Fool

EGFR variant raises lung cancer risk 60-fold in never smokers

A single inherited EGFR mutation may increase lung cancer risk more than 60 times among individuals who never smoked. An evaluation of more than 3 million people showed the EGFR T790M variant increased risk for lung cancer 25 times overall, with a substantially larger impact on patients who reported never smoking…

MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer

MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer GlobeNewswire

A lung cancer treatment showed 90.5% disease control in an interim trial assessment

A lung cancer treatment showed 90.5% disease control in an interim trial assessment stocktitan.net

‘Persistent gaps’ in lung cancer screening communication

Only about one in six U.S. adults eligible for lung cancer screening discussed the procedure with a health care professional in the past year, according to study results. Current smokers and those with comorbidities more often reported having those discussions, a finding researchers say suggests clinicians prioritize…

Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next

Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next Cure Today

How Do Our Genes Shape Our Lung Cancer Risk? - The Mark Foundation for Cancer Research

How Do Our Genes Shape Our Lung Cancer Risk? - The Mark Foundation for Cancer Research Oncodaily

AbbVie’s Bet on Biology: Why One Modality Is Never Enough in Lung Cancer

AbbVie’s Bet on Biology: Why One Modality Is Never Enough in Lung Cancer The Clinical Trial Vanguard

Key Takeaways for Multidisciplinary Lung Cancer Care From WCLC 2026

Ученые нашли препарат, который остановил рак легких с метастазами у 94% пациентов

Ученые нашли препарат, который остановил рак легких с метастазами у 94% пациентов socportal.info

What happens to your lung cancer risk after you quit smoking? Oncologist explains | Health

What happens to your lung cancer risk after you quit smoking? Oncologist explains | Health hindustantimes.com

AI imaging endpoint predicts OS benefit in phase III lung cancer trial: data presented at IASLC WCLC 2026

AI imaging endpoint predicts OS benefit in phase III lung cancer trial: data presented at IASLC WCLC 2026 The Cancer Letter